VAERS Explorer
Back to explore

Report #2860319

Received Sep 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
55 yrs
State
CA
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
FLU3INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURUNKUT8779JAOT

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

HD syringe was administered in error to a 55-year-old patient, with no reported adverse event; Initial information received on 16-Sep-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 55 years old and unknown gender patient who was administered to Influenza Usp Trival A-B Subvirion No Preservative Vaccine [Fluzone] syringe in error, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect Influenza Usp Trival A-B Subvirion No Preservative Vaccine, Suspension for injection (lot UT8779JA, expiry date 30-Jun-2026, strength not eported) via unknown route in unknown administration site for prophylactic vaccination (Immunisation) and was administered in error to a 55-year-old patient, with no reported adverse event (product administered to patient of inappropriate age) (latency same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.